Shimada Mikiko, Nagano Nobuo, Goto Saori, Ito Kyoko, Tsutsui Takaaki, Ando Tetsuo, Kamioka Hiroharu, Ogawa Tetsuya
Medical Corporations Hidaka Rehabilitation Hospital.
J Nutr Sci Vitaminol (Tokyo). 2015;61(4):345-53. doi: 10.3177/jnsv.61.345.
The objective of the present study was to evaluate bowel habits induced by ingestion of 10 g polydextrose (PDX) fed to Japanese hemodialysis (HD) patients. This was a randomized, placebo-controlled, triple-blind, parallel-group controlled, 8-wk study. A total of 50 HD outpatients capable of self-management (51-79 y of age) were recruited at H Clinic, Japan. Inclusion criteria for participation in the study were ingestion of one or more laxative tablets for more than 3 mo and having received HD for more than 6 mo. The participants were randomly assigned to 2 groups: A (0 g polydextrose/d; control), B (10 g polydextrose/d; PDX). The primary outcome measure was stool frequency. Secondary outcomes were stool consistency, abdominal pain, intestinal bloating and clinical biochemistry indexes. PDX had no significant effect on blood biochemistry indexes. The PDX group showed significant improvements in bowel function (stool frequency increased from 3.0 times per week to 7.5 times per week) and reported no laxation problems (abdominal distention, cramps, and diarrhea) (p<0.01). Regular consumption of the PDX products increased dietary fiber intake to recommended levels and improved bowel habits.
本研究的目的是评估给日本血液透析(HD)患者摄入10克聚葡萄糖(PDX)所引起的排便习惯。这是一项随机、安慰剂对照、三盲、平行组对照的8周研究。在日本H诊所招募了总共50名能够自我管理的HD门诊患者(年龄51 - 79岁)。参与研究的纳入标准是服用一种或多种泻药超过3个月且接受HD超过6个月。参与者被随机分为两组:A组(每日0克聚葡萄糖;对照组),B组(每日10克聚葡萄糖;PDX组)。主要结局指标是排便频率。次要结局包括粪便稠度、腹痛、肠胀气和临床生化指标。PDX对血液生化指标无显著影响。PDX组在肠道功能方面有显著改善(排便频率从每周3.0次增加到每周7.5次),且未报告有泻药相关问题(腹胀、痉挛和腹泻)(p<0.01)。定期食用PDX产品可将膳食纤维摄入量提高到推荐水平并改善排便习惯。